Treatment of Cystic Fibrosis and Other Rare Lung Diseases [[electronic resource] /] / edited by Arata Azuma, Michael S. Schechter |
Edizione | [1st ed. 2017.] |
Pubbl/distr/stampa | Basel : , : Springer Basel : , : Imprint : Springer, , 2017 |
Descrizione fisica | 1 online resource (VIII, 263 p. 33 illus., 14 illus. in color.) |
Disciplina | 616.2 |
Collana | Milestones in Drug Therapy |
Soggetto topico |
Pharmacology
Respiratory organs—Diseases Internal medicine Immunology Pharmacology/Toxicology Pneumology/Respiratory System Internal Medicine |
ISBN | 3-0348-0977-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I Etiopathology and Genetics of Rare Lung Diseases -- Part II Treatment of Cystic Fibrosis -- Part III Treatment of Other Rare Lung Diseases. |
Record Nr. | UNINA-9910163029803321 |
Basel : , : Springer Basel : , : Imprint : Springer, , 2017 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Trends in immunology |
Pubbl/distr/stampa | [Oxford, U. K.], : Elsevier Science Ltd., c2001- |
Disciplina | 571.96 |
Soggetto topico |
Immunology
Allergy and Immunology Immunologie - Périodiques |
ISSN | 1471-4981 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910333151503321 |
[Oxford, U. K.], : Elsevier Science Ltd., c2001- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Trends in immunology |
Pubbl/distr/stampa | [Oxford, U. K.], : Elsevier Science Ltd., c2001- |
Disciplina | 571.96 |
Soggetto topico |
Immunology
Allergy and Immunology Immunologie - Périodiques |
ISSN | 1471-4981 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996218692103316 |
[Oxford, U. K.], : Elsevier Science Ltd., c2001- | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Trichloroethylene: Toxicity and Health Risks [[electronic resource] /] / edited by Kathleen M. Gilbert, Sarah J. Blossom |
Autore | Gilbert Kathleen M |
Edizione | [1st ed. 2014.] |
Pubbl/distr/stampa | London : , : Springer London : , : Imprint : Springer, , 2014 |
Descrizione fisica | 1 online resource (249 p.) |
Disciplina | 615.902 |
Collana | Molecular and Integrative Toxicology |
Soggetto topico |
Pharmacology
Epidemiology Molecular biology Immunology Medical biochemistry Environmental health Pharmacology/Toxicology Molecular Medicine Medical Biochemistry Environmental Health |
ISBN | 1-4471-6311-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | History of TCE -- Trichloroethylene and autoimmunity in human and animal.-Hypersensitivity Dermatitis and Hepatitis -- Trichloroethylene-induced oxidative stress and autoimmunity.-Brain and Behavioral Changes in Rodent Models -- Role of Trichloroethylene in Parkinson’s disease -- Neuroimmune effects of developmental TCE exposure -- Environmental sensitivity to trichloroethylene (TCE) in the developing heart -- Trichloroethylene and Cancer -- Epigenetic Alterations Due to Trichloroethylene -- Mathematical Modeling and Trichloroethylene . |
Record Nr. | UNINA-9910298351803321 |
Gilbert Kathleen M | ||
London : , : Springer London : , : Imprint : Springer, , 2014 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Tryptophan Metabolism: Implications for Biological Processes, Health and Disease / / edited by Atilla Engin, Ayse Basak Engin |
Edizione | [1st ed. 2015.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Humana, , 2015 |
Descrizione fisica | 1 online resource (385 p.) |
Disciplina |
610
611.01816 615 616.39 616079 |
Collana | Molecular and Integrative Toxicology |
Soggetto topico |
Pharmacology
Molecular biology Metabolic diseases Immunology Medicine Pharmacology/Toxicology Molecular Medicine Metabolic Diseases Biomedicine, general |
ISBN | 3-319-15630-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | TRYPTOPHAN RELATED SIGNALING MOLECULES: TARGETS AND FUNCTIONS -- TRYPTOPHAN AND CELL DEATH -- TRYPTOPHAN AND NITRIC OXIDE IN ALLERGY.-Tryptophan metabolites: A microbial perspective -- THE ROLE OF L-TRYPTOPHAN KYNURENINE PATHWAY METABOLISM IN VARIOUS INFECTIOUS DISEASES: FOCUS ON INDOLEAMINE 2,3-DIOXYGENASE 1 -- EVALUATION OF TRYPTOPHAN METABOLISM IN CHRONIC IMMUNE ACTIVATION -- DIABETES AND TRYPTOPHAN METABOLISM -- 3-HYDROXYKYNURENIC ACID AND TYPE 2 DIABETES: IMPLICATIONS FOR AGING, OBESITY, DEPRESSION, PARKINSON’S DISEASE AND SCHIZOPHRENIA -- THERAPEUTICAL IMPLICATIONS OF MELATONIN IN ALZHEIMER´S AND PARKINSON´S DISEASES -- TRYPTOPHAN METABOLISM AND SLEEP -- TRYPTOPHAN IN MOLECULAR HEMATOPOIESIS -- NIGHT-SHIFTS AND MELATONIN: RELEVANCE TO AGE AND BREAST CANCER -- CHEMOTHERAPEUTIC AGENTS IN CANCER TREATMENT AND TRYPTOPHAN METABOLISM.-INDOLEAMINE 2,3-DIOXYGENASE-COMPETENT REGULATORY DENDRITIC CELLS AND THEIR ROLE IN ALLOIMMUNE REGULATION AND TRANSPLANT IMMUNE TOLERANCE -- WINE FLAVOR AND TRYPTOPHAN . |
Record Nr. | UNINA-9910298299403321 |
Cham : , : Springer International Publishing : , : Imprint : Humana, , 2015 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Tuberculosis Host-Pathogen Interactions [[electronic resource] /] / edited by Jeffrey D. Cirillo, Ying Kong |
Edizione | [1st ed. 2019.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
Descrizione fisica | 1 online resource (VIII, 255 p. 33 illus., 32 illus. in color.) |
Disciplina | 616.9041 |
Soggetto topico |
Medical microbiology
Immunology Communicable diseases Medical Microbiology Infectious Diseases |
ISBN | 3-030-25381-3 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1.Cell Wall Biosynthesis and Latency During Tuberculosis Infections -- 2. The Silent Plague: Regulation of Latent Tuberculosis Infections -- 3. Trehalose Dimycolate (Cord Factor) as a Contributing Factor to Tuberculosis Pathogenesis -- 4. Role of Myeloid-derived Suppressor Cells and Regulatory T-cells in the Tuberculous Granuloma -- 5. Interactions of Mycobacterium tuberculosis with Human Mesenchymal Stem Cells -- 6. Role of Mycobacterium tuberculosis PE and PPE proteins in pathogen-host interactions -- 7. Co-Infection with TB and HIV: Converging Epidemics, Clinical Challenges, and Microbial Synergy -- 8. Optical In Vivo Imaging in Tuberculosis Research -- 9. Mycobacteria Infection and Lipid Droplets – Host and Pathogen Stealing, Sharing and Storing Fat -- 10. Potential Immunology, Transcriptomics and Epigenomic Prediction Tools of the Future to Improve Tuberculosis Control. |
Record Nr. | UNINA-9910349443603321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Tumor Ablation [[electronic resource] ] : Effects on Systemic and Local Anti-Tumor Immunity and on Other Tumor-Microenvironment Interactions / / edited by Yona Keisari |
Edizione | [1st ed. 2013.] |
Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2013 |
Descrizione fisica | 1 online resource (160 p.) |
Disciplina | 616.9940632 |
Collana | The Tumor Microenvironment |
Soggetto topico |
Medicine
Cancer research Oncology Immunology Radiotherapy Biomedicine, general Cancer Research Oncology |
ISBN |
1-283-63399-X
9786613946447 94-007-4694-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Preface; Contents; Chapter 1 Effect of Chemotherapy on the Tumor Microenvironment and Anti-tumor Immunity; 1.1 Introduction; 1.2 Mechanisms of Cell Death Induced by Anti-cancer Therapy; 1.2.1 Apoptosis; 1.2.2 Non-apoptotic Cell Death; 1.2.3 Morphological vs Functional Classification of Cell Death; 1.3 Immunogenicity of Cell Death; 1.4 Biochemical Features of Immunogenic Cell Death; 1.4.1 Calreticulin Exposure; 1.4.2 Heat Shock Proteins (HSPs); 1.4.3 HMGB1 and TLR Interactions; 1.4.4 ATP Release and Activation of the NLRP3 Inflammasome; 1.4.5 Autophagy-Dependent Immune Responses
1.5 Effects of Chemotherapy on the Immune System1.5.1 Immune-Suppressive Effects; 1.5.1.1 Lymphopenia; 1.5.1.2 Non-immunogenic Cell Death; 1.5.2 Immune-Stimulatory Effects; 1.5.2.1 Enhanced Antigen Delivery and Presentation; 1.5.2.2 Homeostatic Proliferation; 1.5.2.3 Regulatory T Cells; 1.5.2.4 Myeloid Derived Suppressor Cells (MDSCs); 1.5.2.5 DNA-Damage Response and Activation of the Innate Immune System; 1.5.2.6 Gemcitabine; 1.5.2.7 5-Fluorouracil (5FU); 1.5.3 Immune-Modulatory Effects of Targeted Agents; 1.5.3.1 Imatinib; 1.5.3.2 Sunitinib and Sorafenib; 1.6 Conclusion; References Chapter 2 Hyperthermia, the Tumor Microenvironment and Immunity2.1 Introduction; 2.2 Hyperthermia; 2.2.1 Fever Range Heating (FRH); 2.2.2 Hyperthermia Range Heating; 2.2.3 Ablation Range Hyperthermia; 2.3 Conclusions; References; Chapter 3 Radiofrequency Ablation in Cancer Therapy: Tuning in to in situ Tumor Vaccines; 3.1 Introduction; 3.2 RFA Techniques/Parameters and Tumor Cell Death; 3.2.1 Direct Effects; 3.2.2 Indirect Effects; 3.3 Release of Immune-Mediating Factors and `Immunogenic' Cell Death; 3.3.1 Release of Tumor-Antigens; 3.3.2 Release of Immune Stimulating Mediators 3.4 Induction of Immune Responses by RFA: The Tumor Microenvironment3.4.1 Antigen Presentation after Radio Frequency Ablation; 3.4.2 Immunity after Radiofrequency Ablation; 3.4.3 Regulation after Radiofrequency Ablation; 3.5 RFA Combinational Strategies; 3.5.1 Tumor Cytotoxicity; 3.5.2 Immunotherapy; 3.5.2.1 Stimulation of Antigen Presentation; 3.5.2.2 Stimulation of T Cell Reactivity; 3.6 Conclusions and Future Perspective; References; Chapter 4 High Intensity Focused Ultrasound (HIFU) Ablation; 4.1 History of HIFU Tumor Ablation; 4.2 Physical Principles of HIFU Ablation 4.3 Technical Aspects of HIFU Ablation4.4 Direct Thermal and Non-thermal Effects on the Tumor; 4.5 Thermal Effects on Tumor Vasculature; 4.6 Indirect Effects on the Tumor; 4.7 HIFU-Induced Antitumor Immune Response; 4.8 Conclusions; References; Chapter 5 The Interrelationship Between Cryoablation, the Immune Response and the Tumor Microenvironment: Stimulatory and Suppressive Effects; 5.1 Introduction; 5.2 Clinical Use of Cryoablation in Cancer; 5.3 Anecdotal Evidence of Immune Response to Cryoablation; 5.4 How Does Cryoablation Kill Tumors?; 5.4.1 Direct Cellular Injury 5.4.2 Indirect Cellular Injury |
Record Nr. | UNINA-9910437616203321 |
Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy [[electronic resource] /] / edited by Pawel Kalinski |
Edizione | [1st ed. 2017.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 |
Descrizione fisica | 1 online resource (XIV, 264 p. 47 illus., 43 illus. in color.) |
Disciplina | 616.994079 |
Collana | Advances in Experimental Medicine and Biology |
Soggetto topico |
Cancer research
Oncology Immunology Molecular biology Cancer Research Oncology Molecular Medicine |
ISBN | 3-319-67577-X |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part 1. Interplay Between Tumor Cells, Stroma and Inflammatory Infiltrate in Regulating Tumor Micro-Environment -- Tumor Immuno-Environment in Cancer Progression and Therapy -- Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment -- Regulation of CTL Infiltration Within the Tumor Microenvironment -- The Role of Tumor Microenvironment in Cancer Immunotherapy -- Part 2. Mediators of Tumor Microenvironment -- Immunogenic and Non-Immunogenic Cell Death in the Tumor Microenvironment -- Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression -- Chemo-immunotherapy: Impact of Indoleamine 2,3-dioxygenase in Defining Immunogenic versus Tolerogenic Cell Death in the Tumor Microenvironment -- Targeting Myeloid-Derived Suppressor Cells in Cancer -- Tryptophan catabolism and cancer immunotherapy targeting IDO mediated immune Suppression -- Part 3. Emerging Targets and Technologies of Modulation of Tumor Microenvironment -- Tumor Microenvironment in Cancer Progression and Therapy -- The Role of the Immune System and Immunoregulatory Mechanisms Relevant to Melanoma -- Oncolytic Virotherapy and the Tumor Microenvironment -- The Impact of Housing Temperature Induced Chronic Stress on Preclinical Mouse Tumor Models and Therapeutic Responses: An Important Role for the Nervous Role for the Nervous System -- (Immuno)therapeutic Targeting of Tumor-Associated Blood Vessels -- Adaptive Resistance to Cancer Immunotherapy -- Imaging the Tumor Microenvironment. |
Record Nr. | UNINA-9910253958003321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
The Tumor Immunoenvironment [[electronic resource] /] / edited by Michael R Shurin, Viktor Umansky, Anatoli Malyguine |
Edizione | [1st ed. 2013.] |
Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2013 |
Descrizione fisica | 1 online resource (745 p.) |
Disciplina |
616.99
616.994079 |
Soggetto topico |
Cancer research
Oncology Immunology Life sciences Medicine Cancer Research Oncology Life Sciences, general Biomedicine, general |
ISBN | 94-007-6217-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Preface -- Introduction -- Role of the immunological environment in cancer initiation, development and progression -- Part I Tumor Microenvironment and Immunoenvironment -- The metastatic microenvironment -- Tumor infiltration by immune cells: pathologic evaluation and a clinical significance -- Immunologic interpretation of cancer biology: impact on clinical outcome -- Part II Developmental Characteristics of the Tumor ImmunoEnvironment -- Development of antitumor cellular immunity -- The versatile world of inflammatory chemokines in cancer.-Inflammation, Tumor Progression, and Immune Suppression -- Pleiotropic and differential functions of IL-1a and IL-1b shape the tumor microenvironment and affect the outcome of malignancies -- Impact of obesity and aging on the tumor immunoenvironment -- Part III Tumor Escape from Immune Recognition -- MHC class I antigens and the tumor microenvironment -- Tumor-produced immune regulating factors -- Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments.- T cell malfunction in the tumor environment -- Signaling of tumor-induced immunosuppression of dendritic cells -- Tumor microenvironment may shape the function and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells -- Part IV Immune Regulators in the Tumor ImmunoEnvironment -- The role of myeloid-derived suppressor cells in cancer -- Macrophage differentiation and activation states in the tumor microenvironment -- Dendritic cells and cancer: development, dysfunction and therapeutic targets -- The role of tumor-associated neutrophils in cancer -- Mast cell modulation of the tumor microenvironment -- Regulatory T cells in patients with cancer -- Tumor-evoked regulatory B cells as important mediators of cancer escape -- Part V Tumor Escape and Cancer Immunotherapy -- Cancer immunotherapy: Overview in brief -- Programming of MDSC: New opportunities for targeted therapy -- Therapeutic targeting regulatory T cells in tumor.-ChemoImmunoModulation: Focus on myeloid regulatory cells -- Combining vaccines with therapies that render tumor cells more susceptible to immune mediated killing -- Prophylactic Cancer Vaccines -- Part VI Analyzing Immune Responses in Cancer -- Approaches to Immunologic Monitoring of Clinical Trials -- Evaluation of the tumor immunoenvironment in clinical trials -- Analysis of Myeloid-derived Suppressor Cells in Patients with Cancer -- When results of T cell immune monitoring match or do not match clinical outcomes of tumor vaccine trials - what more could and should we measure? |
Record Nr. | UNINA-9910437855403321 |
Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Tumor Microenvironment [[electronic resource] /] / edited by Peter P. Lee, Francesco M. Marincola |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
Descrizione fisica | 1 online resource (XXIV, 326 p. 61 illus., 56 illus. in color.) |
Disciplina | 616.994079 |
Collana | Cancer Treatment and Research |
Soggetto topico |
Oncology
Immunology Oncology |
ISBN | 3-030-38862-X |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Preface -- Part I: Imaging of tumor microenvironment, In vivo Imaging -- New technologies to image tumors -- Part II: Immune landscapes and their biology, Systemic correlates of the tumor microenvironment -- Adaptive immunity and the tumor microenvironment -- The biology of immune active cancers and their regulatory mechanisms -- The biology of immune excluded cancers -- Immunoscore -- Part III: The tumor microenvironment and therapy, The Immune Landscape in Women Cancers -- Translational biomarkers, combination therapies and their relationship with immune landscapes -- Effects of radiation on the tumor microenvironment -- Challenges of CAR T cell therapy for solid tumors. |
Record Nr. | UNINA-9910383832303321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|